[ Price : $8.95]
FDA has accepted for filing a Mylan ANDA for a three-times-per-week glatiramer acetate injection 40 mg/mL, a generic of Tevas MS d...[ Price : $8.95]
BIO and Novartis voice disagreement with FDAs proposed use of Phonetic and Orthographic Computer Analysis scores in determining th...[ Price : $8.95]
University of Toronto researchers analyzing a cardiovascular trial registry find that in clinical trials that included heart attac...[ Price : $8.95]
Federal Register Notice: FDA releases for comment 10 tobacco product applications from Swedish Match North America.[ Price : $8.95]
DePuy Synthes recalls certain lots of its Craniomaxillofacial Distraction System because the device may reverse direction and lose...[ Price : $8.95]
Software maker Accelrys describes the regulatory importance of data integrity and audit trails in the U.S. and EU.[ Price : $8.95]
FDA grants Amgen a priority review designation for its NDA for ivabradine for treating chronic heart failure.[ Price : $8.95]
Attorney Shashank Upadhye says drug companies must create a cGMP culture of compliance based on employee training.